NeoGenomics, Inc. (NEO) Investor Relations Documents

NeoGenomics, Inc. (NEO) investor relations documents from the company's IR site: 15 presentations, 24 press releases; latest deck 2026-04-28. Read in-app with summaries. First-party data.

PresentationPDF: NeoGenomics Q1 2026 results show 11% revenue growth to $187M and 27% adjusted EBITDA growth, driven by NGS expansion and the launch of RaDaR ST.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-07-20Press releaseNeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS
2026-07-07Press releaseNeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026
2026-06-25Press releaseNeoGenomics Appoints Carolyn Starrett to its Board of Directors
2026-05-26Press releaseDownload as PDF
2026-05-15Press releaseNeoGenomics to Participate in Upcoming Investor Conferences
2026-05-15Press releaseDownload as PDF
2026-04-28Press releaseNeoGenomics Reports First Quarter 2026 Results
2026-04-28PresentationPresentationPDF
2026-04-28Press releaseDownload as PDF
2026-04-07Press releaseNeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
2026-03-10PresentationNeoGenomics Investor Presentation – March 2026
2026-02-17PresentationNeoGenomics Investor Presentation – February 2026
2026-01-27Press releaseNeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
2026-01-10PresentationNeoGenomics at JP Morgan Healthcare Conference 2026
2025-10-28PresentationPresentationPDF
2025-10-14Press releaseNeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
2025-07-29PresentationPresentationPDF
2025-04-29PresentationPresentationPDF
2025-02-18PresentationPresentationPDF
2025-01-29Press releaseNeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
2025-01-15Press releaseNeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
2024-11-05PresentationPresentationPDF
2024-10-15Press releaseNeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024
2024-07-29Earnings deckPresentationPDF
2024-07-09Press releaseNeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024
2024-04-30Earnings deckPresentationPDF
2024-04-09Press releaseNeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
2024-03-18ESG reportInaugural Report
2024-02-20Earnings deckPresentationPDF
2024-01-30Press releaseNeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024
2023-11-06Earnings deckPresentationPDF
2023-11-06Press releaseEarnings ReleaseHTML
2023-10-17Press releaseNeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
2023-08-08PresentationPresentationPDF
2023-08-08Press releaseEarnings ReleaseHTML
2023-07-18Press releaseNeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
2023-05-08Earnings deckPresentationPDF
2023-05-08Press releaseEarnings ReleaseHTML
2023-05-03Press releaseNeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference
2023-04-17Press releaseNeoGenomics to Announce First Quarter 2023 Financial Results

NEO overview · NEO earnings · NEO financials · NEO KPIs · NEO documents · NEO ownership · NEO peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.